SCHEMBL25190452

SCHEMBL25190452

NCc1ccc(Nc2ccc(F)c(N3CCCCCC3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.38
▸ HTT P42858 3/20 0.38
▸ P2RX3 P56373 4/20 0.38
▸ KCNQ2 O43526 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ ACP1 P24666 1/20 0.35
▸ GFER P55789 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GALR2 O43603 2/20 0.35
▸ GALR1 P47211 1/20 0.35
▸ PRMT6 Q96LA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25193451 0.99 KCNQ2 (0.38) ALDH1A1HTTP2RX3KCNQ2GAA
SCHEMBL13736051 0.82 ALDH1A1 (0.42) ALDH1A1HTTKCNQ2GAACSF1R
SCHEMBL25190301 0.82 KMT2A (0.39) ALDH1A1HTTCSF1RACP1GFER
SCHEMBL25201540 0.80 S1PR1 (0.42) —
SCHEMBL25190432 0.77 MAPT (0.47) ALDH1A1HTTGAAGFERKDM4E
SCHEMBL25190342 0.76 MAPT (0.47) ALDH1A1HTTGAAGFERKDM4E
SCHEMBL4027973 0.74 ALDH1A1 (0.50) ALDH1A1HTTGAACSF1RGFER
SCHEMBL4023577 0.74 ALDH1A1 (0.50) ALDH1A1HTTGAACSF1RGFER
SCHEMBL4029065 0.74 ALDH1A1 (0.50) ALDH1A1HTTGAACSF1RGFER
SCHEMBL4024455 0.72 ALDH1A1 (0.51) ALDH1A1HTTKCNQ2GAACSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 ALDH1A1 395/4885HTT 2801/4885P2RX3 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback